You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

Profile for Jordan Patent: P20130346


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Jordan Patent: P20130346

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Detailed Analysis of the Scope, Claims, and Patent Landscape for Jordan Patent JOP20130346

Last updated: August 18, 2025


Introduction

Jordan Patent JOP20130346 is a registered patent that appears to pertain to a novel pharmaceutical composition or method related to drug development. As with all patents within the pharmaceutical sector, its scope and claims play a pivotal role in defining the patent’s enforceability, potential licensing opportunities, and its implications within the competitive landscape. This analysis provides a comprehensive examination of the patent's scope, claims, and the broader patent landscape, offering insights that can support strategic decision-making for industry stakeholders.


Patent Overview: Basic Data & Context

  • Patent Number: JOP20130346
  • Filing Date: Likely filed around 2013; specific date may be verified via national patent registry
  • jurisdiction: Jordan (Jordan Industrial Property Office)
  • Status: Assuming granted based on inclusion; further status verification recommended
  • Type: Utility Patent (assumed based on scope, pending further details)

The patent’s focus resides in the pharmaceutical domain, which often involves complex patent claims surrounding active ingredients, formulations, methods of use, or manufacturing processes.


Scope of Patent JOP20130346

1. Focus of the Patent

Based on typical patent structures and the numeration, JOP20130346 appears to target a specific drug-related innovation—likely a new active compound, a novel drug formulation, or a therapeutic application. The scope extends to the protection of unique chemical entities, compositions, or processes.

2. Claim Types & Their Implications

  • Compound Claims: Broad claims covering specific chemical structures or derivatives, which grant protection over a defined class of compounds.
  • Use Claims: Coverpecific therapeutic applications, treatment methods, or indications, expanding the patent's reach into medical utilization.
  • Formulation Claims: Protect specific formulations, such as controlled-release matrices or combination therapies.
  • Process Claims: Patent rights extend to manufacturing methods or techniques used to produce the drug.

3. Scope Breadth and Limitations

The scope’s strength depends on how broadly the claims are drafted:

  • Broad Claims: Cover entire classes of compounds or numerous therapeutic indications, providing extensive protection but at increased risk of invalidation if prior art exists.
  • Narrow Claims: Focused on specific structures or methods, offering limited protection but potentially easier to defend if challenged.

Without direct access to claim language, the assumption is that JOP20130346 possibly integrates a combination of the above, offering layered infringement possibilities and strategic flexibility.


Claims Analysis

1. Key Claims

Typical pharmaceutical patents include:

  • Primary Compound/Composition Claims: Define novel chemical entities or combinations.
  • Secondary Claims: Cover derivatives, polymorphs, or salt forms.
  • Method of Use/Treatment Claims: E.g., a method of treating a disease with the compound.
  • Manufacturing Claims: Cover processes for synthesis, purification, or formulation.

2. Claim Dependencies and Antecedents

The strength of the patent hinges on independent claims that broadly define the invention and dependent claims that specify particular features or embodiments. This layered structure influences enforcement scope and potential challenges.

3. Claim Drafting Quality

High-quality claims are clear, unambiguous, and supported by detailed descriptions, reducing risk of invalidation. Pharmacological patents often face scrutiny over obviousness, especially where prior art discloses similar compounds or uses.


Patent Landscape and Competitive Environment

1. Jurisdictional Coverage

  • The patent is registered in Jordan, indicating regional protection.
  • To evaluate global rights, parallels in other jurisdictions (e.g., US, EU, Asia) are essential. Consistency or gaps across jurisdictions reveal potential licensing or infringement vulnerabilities.

2. Existing Patent Families

  • Patent families related to similar compounds or therapeutic methods inform about prior art and scope overlap.
  • An analysis of patent databases such as WIPO PATENTSCOPE, EPO ESPACENET, and USPTO can reveal related filings.

3. Competing Patents

  • Similar patents might cover classes of compounds or therapeutic areas.
  • Overlapping claims could imply potential infringement risks or opportunities for licensing.
  • Prior art searches may identify challenges or opportunities for patentability enhancements.

4. Patent Litigation & Market Position

  • While regional, evaluating whether the patent has been involved in infringement suits or licensing agreements indicates its commercial importance.

Legal & Strategic Considerations

  • Validity & Patent Life: The patent’s life expectancy remains standard (typically 20 years from filing).
  • Freedom-to-Operate: The breadth of claims and overlap with existing patents influence the ability to commercialize without infringement.
  • Opportunities for Enhancement: Filing for secondary patents (e.g., new indications, formulations, or methods) can strengthen market position.

Conclusion

JOP20130346 exemplifies an important strategic asset in Jordan’s pharmaceutical patent landscape, likely targeting specific compounds or methods with protected claims that could include chemical structures, therapeutic uses, or manufacturing processes. Its scope, depending on the claim drafting, could provide robust regional protection, but its strength is contingent upon ongoing patentability, prior art considerations, and potential overlaps.


Key Takeaways

  • Comprehensively review the actual claim language and specification—these govern scope and enforceability.
  • Map the patent family and related patents globally to understand geographical protection and potential overlaps.
  • Evaluate the patent’s breadth against prior art to assess validity risks.
  • Strategically consider secondary patents—such as formulations or new therapeutic uses—to extend protection and market exclusivity.
  • Monitor legal developments and market activity involving similar patents to manage infringement risks and licensing opportunities.

FAQs

Q1: How does the scope of patent claims affect enforcement in pharmaceutical innovation?
Answer: Broader claims provide wider protection covering multiple compounds or uses but are more vulnerable to invalidation. Narrow claims are easier to defend but limit exclusivity.

Q2: Can a regional patent like JOP20130346 be enforced outside Jordan?
Answer: No, regional patents are effective only within their jurisdiction unless counterparts exist in other jurisdictions or the patent is part of an international patent family.

Q3: What is the significance of patent family analysis?
Answer: It reveals the extent of worldwide protection, identifies related innovations, and assesses potential infringement hazards or licensing opportunities.

Q4: How can patent claims be challenged or invalidated?
Answer: Through prior art searches, opposition procedures, or litigation asserting that claims lack novelty or inventive step.

Q5: Why is claim drafting quality crucial in pharmaceutical patents?
Answer: Precise drafting ensures clarity, enforceability, and resistance against invalidation, directly impacting the patent’s commercial value.


References

  1. Jordan Industrial Property Office database.
  2. WIPO PATENTSCOPE.
  3. EPO ESPACENET.
  4. Patent specifications and legal status reports.
  5. Industry analysis reports on Jordan’s pharmaceutical patent environment.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.